Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

APGEAPGE
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in APOGEE THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 1.7M shares of APGE (APOGEE THERAPEUTICS INC), worth $224.8M as of 2026-Q2. The position was increased (+159.5% shares). APGE represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$224.8M

Current Shares

1.7M

Total Value Change

+$206.3M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+159.5%
$224.8M0.0%$132.73
49
2026-Q1
Increased
652,590
+15.4%
$54.9M0.0%$68.50
34
2025-Q4
Decreased
565,410
-5.7%
$42.7M0.0%$75.76
0
2025-Q3
Decreased
599,616
-9.0%
$23.8M0.0%$39.83
0
2025-Q2
Increased
659,186
+126.8%
$28.6M0.0%$43.38
46
2025-Q1
Decreased
290,699
-28.8%
$10.9M0.0%$39.72
0
2024-Q4
New
408,019
-
$18.5M0.0%$44.64
39

Other major holders of APGE: FMR LLC, BlackRock, Inc., HBK INVESTMENTS L P, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used